Is this you? Create Your Porfile
Avatar

Andreas Harstrick

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Andreas Harstrick is active.

Explore More

Publication

Featured researches published by Andreas Harstrick.

Radiotherapy and Oncology | 2005

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

Mechthild Krause; Gernot Ostermann; Cordula Petersen; Ala Yaromina; Franziska Hessel; Andreas Harstrick; Albert J. van der Kogel; Howard D. Thames; Michael Baumann

Radiotherapy and Oncology | 2005

Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC

M. Krause; Christina Schütze; Cordula Petersen; N. Pimentel; Franziska Hessel; Andreas Harstrick; Michael Baumann

Archive | 2002

COMBINATION THERAPY USING ANTI-EGFR ANTIBODIES AND ANTI-HORMONAL AGENTS

Oliver Rosen; Andreas Harstrick

Archive | 2007

Specific therapy using integrin ligands for treating cancer

Simon Dr. Goodman; Martin Andreas Picard; Johannes Nippgen; Andreas Harstrick; Ulrike Grimm; Matthias Grell; R. Stupp; Michael Weller; Tom Mikkelsen

Archive | 2008

Integrin ligands for use in treating colon cancer

Stefan Krueger; Simon Goodman; Andreas Harstrick; Martin Andreas Picard; Johannes Nippgen; Ulrike Grimm; R. Stupp; Michael Weller

Archive | 2013

SPECIFIC THERAPEUTIC METHOD USING INTEGRIN LIGAND FOR TREATING CANCER

Goodman Simon; Picard Martin Andreas; Tom Mikkelsen; Johannes Nippgen; Grimm Ulrike; Stupp Roger; Michael Weller; Andreas Harstrick; Grell Matthias

Archive | 2008

Integrin-liganden zur verwendung in der behandlung von krebs

Stefan Krueger; Simon Goodman; Andreas Harstrick; Martin Picard; Johannes Nippgen; Ulrike Grimm; R. Stupp; Michael Weller

Archive | 2008

Terapia y medicamento específicos usando ligandos de integrinas para el tratamiento del cáncer

Stefan Krueger; Simon Goodman; Andreas Harstrick; Martin Picard; Johannes Nippgen; Ulrike Grimm; R. Stupp; Michael Weller

Archive | 2008

Integrin ligands for use in treating cancer

Stefan Krueger; Simon Goodman; Andreas Harstrick; Martin Andreas Picard; Johannes Nippgen; Ulrike Grimm; R. Stupp; Michael Weller

Archive | 2008

Integrin for use in the treatment of cancer

Michael Weller; Ulrike Grimm; Simon Goodman; Andreas Harstrick; Stefan Krueger; Martin Picard; Johannes Nippgen; R. Stupp

Explore More

Collaboration

Dive into the Andreas Harstrick's collaboration.

Top Co-Authors
Avatar

Johannes Nippgen

Merck

View shared research outputs
Top Co-Authors
Avatar

Michael Weller

Merck

View shared research outputs
Top Co-Authors
Avatar

R. Stupp

Merck

View shared research outputs
Top Co-Authors
Avatar

Ulrike Grimm

Merck

View shared research outputs
Top Co-Authors
Avatar

Martin Picard

Columbia University Medical Center

View shared research outputs
Top Co-Authors
Avatar

Stefan Krueger

Merck

View shared research outputs
Top Co-Authors
Avatar

Tom Mikkelsen

Merck

View shared research outputs
Top Co-Authors
Avatar

Simon Goodman

Merck KGaA

View shared research outputs
Top Co-Authors
Avatar

Martin Andreas Picard

Merck

View shared research outputs
Top Co-Authors
Avatar

Simon Dr. Goodman

Merck

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge